Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancerLenka N.C. Boyd, Geert Kazemier, Jisce R. Puik et al.|The Journal of Liquid Biopsy|2024Cited by 4